Research article · 2014
Conference abstractPublished 20 Jun 2016
Novel cholesterol based siRNA lipoplexes with and without PEG-modification: Characterization and in vitro cytotoxicity studies
University of KwaZulu-Natal, South Africa
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cationic liposomes have potential in carrying small interfering RNA (siRNA) molecules as gene medicines. However, unfavorable liposome-serum interactions often limit their efficacy. In order to address this concern, liposome-stabilizing agents, cholesterol (Chol) and polyethylene glycol (PEG) were incorporated in the design of new liposome-siRNA systems. The helper lipid, Chol, was combined in equimolar quantities with the cytofectin, N,N-dimethylaminopropylamidosuccinylc holesterylformylhydrazide (MS09), to give unilamellar vesicles. For PEG-modification, distearoylphosphatidylethanolamine poly(ethylene glycol) 2000 was added at 2 mol %. Electrostatic association of liposomes with siRNA was followed in band shift and fluorescence quenching assays. Liposome-siRNA complexes (lipoplexes) were observed as globular aggregates by cryo-transmission electron microscopy. Characterization of lipoplexes by Zeta-potential Nanoparticle Tracking Analysis (Z-NTA) showed that lipoplex size and zeta potential were dependent on both liposome composition and the MS09:siRNA (w/w) mixing ratio. siRNA within lipoplexes resisted serum-induced damage at MS09:siRNA (w/w) ratios of 12:1-32:1. The effects of lipoplexes on cell growth were evaluated with a non-targeting siRNA sequence in transformed and non-transformed human cell lines. MTT and alamarBlueÃ?® assays showed that MCF-7 and HEK293 cells retained at least 78% viability at final siRNA and lipid concentrations of 57 nM and 29-60 Ã?¼M, respectively. In general, cell survival profiles of MS09/Chol and MS09/ Chol/PEG liposomes compared favorably with that of LipofectamineâÂ?¢ 3000 and control formulations which contained the conventional helper lipid, dioleoylphosphatidylethanolamine (DOPE). At present, the siRNA delivery capability of liposomes is under assessment and the most promising formulations will be applied to the delivery of oncogene-specific siRNA in gene silencing experiments.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 31 Mar 2011
PEG-400: prompted eco-friendly synthesis of some novel pyrazolo [1, 5-a] pyrimidine derivatives and their in vitro antimicrobial evaluation
Conference abstract · 24 Sep 2018
Novel carbopol-based niosomal gel of Annona muricata leaves extract for skin cancer treatment: in vitro characterization and in vivo study
Conference abstract · 16 Apr 2018
Novel carbopol-based niosomal gel of Annona muricata leaves extract for skin cancer treatment: In vitro characterization and in vivo study
Conference abstract · 10 Jul 2013
Next generation siRNA technology for HT screening - Combining novel siRNA design and LNA® chemical modification for enhanced specificity without compromising performance
More from this journal
The newest in Journal of Pharmaceutical Care & Health Systems.
Review article · 9 Jun 2025
Blood Fluid: The Unseen Currents That Bind Life and Death Together
Research article · 8 Jun 2025
Formulation and Antibacterial Evaluation of Acmella olaracea (Akarkara) Gummies Used for Toothache
Research article · 9 Apr 2025
Deep Vein Thrombosis: A Closer Look at a Silent Threat
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Care & Health Systems
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Saffiya Habib”
- BylineArticles whose byline prints “Mario Ariatti”
- BylineArticles whose byline prints “Moganavelli Singh”

